ImmunityBio, Inc.
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulato…
Biotechnology
US, San Diego [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared ImmunityBio, Inc. (IBRX) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 322,968.55 | 19,742.55 | 1,263.98 | 702.63 | 1,019.39 | 0.00 | 22.3386 | 45.16 | -0.7664 | -19.4989 | -0.08 | -0.09 | 6.6543 | - - | ||
| Maximum | - - | - - | - - | 37,952,714.00 | 881,933.00 | 85,592.00 | 99,050.00 | 262,089.00 | 0.02 | 781.2500 | 2,849.43 | 3.0051 | 85.3485 | 0.15 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -164.8536 | -132.82 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0844 | - - | ||
| Krystal Biotech, Inc. KRYS | 187.12 | 1.38 0.74% | 152 vs. 235 | 5,381.00 | 45.00 | 0.00 | 14.00 | -268.00 | 0.0300 | 1336.3467 | 0.0000 | 0.9465 | 0.0206 | 0.0012 | 0.0011 | 12.2870 | 28.00 | ||
| Vir Biotechnology, Inc. VIR | 7.82 | -0.27 -3.34% | 681 vs. 1,200 | 1,076.00 | 56.00 | -65.00 | -111.00 | -303.00 | -0.4800 | -5.2847 | 0.0000 | 0.9188 | -1.1579 | -0.0422 | -0.0364 | 12.4686 | 137.00 | ||
| Reata Pharmaceuticals, Inc. RETA | 172.36 | 0.04 0.02% | 1,909 vs. 954 | 6,566.00 | 22.00 | 192.00 | -70.00 | -1,490.00 | 5.1200 | 5.4820 | 0.0000 | 0.9628 | 8.4849 | 2.2110 | 0.3840 | 2.8209 | 38.00 | ||
| CureVac N.V. CVAC | 3.27 | 0.06 1.71% | 463 vs. 498 | 732.00 | 12.00 | -70.00 | -101.00 | -1,636.00 | -0.3100 | -2.2038 | 0.0000 | -2.3694 | -5.7022 | -0.1579 | -0.1022 | 2.0371 | 224.00 | ||
| TG Therapeutics, Inc. TGTX | 31.65 | -0.02 -0.06% | 1,783 vs. 3,604 | 4,926.00 | 63.00 | -10.00 | -8.00 | -1,525.00 | -0.0732 | -50.4229 | 0.0000 | 0.9130 | -0.1687 | -0.0669 | -0.0287 | 2.7564 | 155.00 | ||
| Madrigal Pharmaceuticals, Inc. MDGL | 306.55 | -6.22 -1.99% | 168 vs. 408 | 6,685.00 | 0.00 | -147.00 | -149.00 | -1,483.00 | -7.3800 | -8.6674 | 0.0000 | 0.0000 | 0.0000 | -0.1734 | -0.1363 | 9.2623 | 21.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.